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Table 1. Patient characteristics 
Attribute No. (%)
No. of patients 769
Age (yr) 20-85 (median, 53)
   ≤50   332 (43.2)
   >50  437 (56.8)
FIGO stage
   IA  8 (1.0)
   IB 314 (40.8)
   IIA  134 (17.4)
   IIB 207 (26.8)
   IIIA  5 (0.7)
   IIIB  60 (7.8)
   IVA 25 (3.3)
   IVB  16 (2.1)
Histopathology
   Squamous 627 (81.5)
   Adenocarcinoma 96 (12.5)
   Others 46 (5.9)
Lymph node involvement
   Positive 378 (49.2)
   Negative 390 (50.7)
Tumor size* (cm)
   ≤4   260 (33.8)
   >4    509 (66.2)
Bladder invasion 25/590 (4.2)
Rectal invasion 7/735 (1.0)
*Median, 4 cm; mean, 4.3±1.7 cm.
Table 3. Diagnostic ability of imaging modalities in rectal or bladder invasion
　 Sensitivity Specificity PPV NPV Accuracy
Bladder invasion
   CT 68.2 96.4 51.7 98.2 94.9
   MRI 88.0 93.1 35.6 99.4 92.8
   CT & MRI  90.9 91.7 39.2 96.6 -
Rectal invasion
   CT 85.7 98.9 54.5 99.8 98.7
   MRI 85.7 98.9 42.9 99.7 98.6
   CT & MRI  85.7 99.1 42.9 99.8 -
PPV, positive predictive value; NPV, negative predictive value.
Values are presented as percentage (%).
Table 2. Correlation of imaging findings with endoscopic findings for 
rectal and bladder invasion
Bladder invasion Rectal invasion
CT MRI CT MRI
True positive 15 12 6 6
False positive 14 38 5 8
True negative 375 509 466 701
False negative 7 3 1 1Indications for endoscopy according FIGO staging for cervical cancer 




































































Table 4. Summary of studies showing the capabilities of CT alone or CT and MRI in bladder invasion
Study No. of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Janus et al. [16] 22 40 100 100 85 86
Sundborg et al. [14] 42 100 96 60 100 96
Liang et al. [4]. 100 100 98 80 100 98
Sharma et al. [12] 305 100 92 40 100 92
This study 411 68.2 96.4 51.7 98.2 94.9
Chung et al. [15]* 296 100 98 57 100 98
This study* 397 90.9 91.7 39.2 96.6 -
PPV, positive predictive value; NPV, negative predictive value.














































Fig. 1. A 37-year-old woman who was 
dia  gnosed with squamous cell carcinoma 
of the uterine cervix. Magnetic resonance 
imaging (A, axial; B, sagittal) shows that 
the mass is focally in contact with the 
posterior wall of the bladder, and there 
is a fat plane and no definitive evidence 
of invasion. Cystoscopic finding (C) of an 
erythematous flat elevated lesion that is 
present on the bladder posterior wall.Indications for endoscopy according FIGO staging for cervical cancer 
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